| Size | Price | Stock | Qty |
|---|---|---|---|
| 5g |
|
||
| Other Sizes |
|
| Targets |
Human Endogenous Metabolite Microbial Metabolite
|
|---|---|
| References |
[1]. Hernández AG, et, al. The determination of acid-soluble nucleotides in milk by improved enzymic methods: a comparison with the ion-exchange column chromatography procedure. J Sci Food Agric. 1981 Nov;32(11):1123-31.
|
| Additional Infomation |
Cytidine 5'-monophosphate is a pyrimidine ribonucleoside 5'-monophosphate having cytosine as the nucleobase. It has a role as a human metabolite, an Escherichia coli metabolite and a mouse metabolite. It is a pyrimidine ribonucleoside 5'-monophosphate and a cytidine 5'-phosphate. It is a conjugate acid of a cytidine 5'-monophosphate(2-).
A pyrimidine ribonucleoside 5'-monophosphate having cytosine as the nucleobase. Cytidine monophosphate is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). Cytidine-5'-monophosphate has been reported in Drosophila melanogaster, Mycoplasma gallisepticum, and other organisms with data available. Cytidine monophosphate is a metabolite found in or produced by Saccharomyces cerevisiae. Cytidine (dihydrogen phosphate). A cytosine nucleotide containing one phosphate group esterified to the sugar moiety in the 2', 3' or 5' position. See also: Polyinosinic-polycytidylic acid (low MW) (monomer of); Polyinosinic-Polycytidylic Acid (High MW) (monomer of) ... View More ... |
| Molecular Formula |
C9H14N3O8P
|
|---|---|
| Molecular Weight |
323.20
|
| Exact Mass |
323.051
|
| CAS # |
63-37-6
|
| Related CAS # |
Cytidine 5′-monophosphate-15N3 disodium
|
| PubChem CID |
6131
|
| Appearance |
White to off-white solid powder
|
| Density |
2.2±0.1 g/cm3
|
| Boiling Point |
662.8±65.0 °C at 760 mmHg
|
| Melting Point |
~222 °C (dec.)
|
| Flash Point |
354.6±34.3 °C
|
| Vapour Pressure |
0.0±4.6 mmHg at 25°C
|
| Index of Refraction |
1.775
|
| LogP |
-2.03
|
| Hydrogen Bond Donor Count |
5
|
| Hydrogen Bond Acceptor Count |
8
|
| Rotatable Bond Count |
4
|
| Heavy Atom Count |
21
|
| Complexity |
531
|
| Defined Atom Stereocenter Count |
4
|
| SMILES |
C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O
|
| InChi Key |
IERHLVCPSMICTF-XVFCMESISA-N
|
| InChi Code |
InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1
|
| Chemical Name |
[(2R,3S,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O: 18.33 mg/mL (56.71 mM)
DMSO: 1.1 mg/mL (3.40 mM) |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: 11.11 mg/mL (34.37 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication (<60°C).
(Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.0941 mL | 15.4703 mL | 30.9406 mL | |
| 5 mM | 0.6188 mL | 3.0941 mL | 6.1881 mL | |
| 10 mM | 0.3094 mL | 1.5470 mL | 3.0941 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
